PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

#NICE

Tag

NICE invites feedback on health technology evaluations manual

NICE invites feedback on health technology evaluations manual

The UK’s National Institute for Health and Care Excellence (NICE) has opened a public consultation on the first updates to its health technology evaluations manual, which was published in January 2022.

11 Jul 2023
Read More
UK’s ‘Pro-innovation Regulation of Technologies Review – Life Sciences’ report outlines regulatory opportunities to speed market access

UK’s ‘Pro-innovation Regulation of Technologies Review – Life Sciences’ report outlines regulatory opportunities to speed market access

The ‘Pro-innovation Regulation of Technologies Review – Life Sciences’, published at the end of May 2023, highlights areas where improvements can be made to the UK’s regulatory environment to further enable innovation and a thriving life sciences sector. It presents ambitious ideas on developing innovation pathways and ways to support and retain talent in the regulatory organisations to ensure speed to market for new products.

7 Jun 2023
Read More
Developments in UK mental health treatments

Developments in UK mental health treatments

With Mental Health Awareness Week 2023 having taken place from 15-21 May and focusing on anxiety, what advances have there been in this field to support those with mental health conditions? We examine the status of mental health therapy demand in the UK and whether the provision of digitally enabled treatments could be one way to help ease waiting times.

23 May 2023
Read More
NICE extends international collaboration to streamline processes

NICE extends international collaboration to streamline processes

The UK’s National Institute for health and Care Excellence (NICE) has announced that it will be working closely with the Canadian Agency for Drugs and Technologies in Health (CADTH) and the US Institute for Clinical and Economic Review (ICER) to find common ground and smooth processes around the handling of confidential information about health technologies.

4 May 2023
Read More
BIA calls on NICE to update evidence on rare disease medicines

BIA calls on NICE to update evidence on rare disease medicines

New research has found that the public believes a new approach should be adopted for making funding decisions about treatments for rare diseases. The report ‘Rare insights: examining the social values of treating rare diseases’, was commissioned by the UK BioIndustry Association’s (BIA) Rare Disease Industry Group (RDIG).

20 Apr 2023
Read More
MHRA and NICE get Wellcome funding for regulation of mental health products

MHRA and NICE get Wellcome funding for regulation of mental health products

Wellcome has awarded £1.8m to the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) so that they can investigate and produce guidance on regulation of digital mental health tools.  

7 Nov 2022
Read More
NICE develops proportionate approach to technology appraisals

NICE develops proportionate approach to technology appraisals

The National Institute for Health and Care Excellence (NICE) plans to speed up its processes for evaluating lower-risk treatments using a lighter touch approach. This will free up time to consider the increasing number of more complex applications. NICE states that this method will make its assessments faster, enabling quicker access to promising new treatments.

1 Nov 2022
Read More

Categories

  • Awards
  • Consultants
  • Events
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #BIA #cancer #ClinicalTrials #drugapprovals #drugpricing #drugregulation #EC #EFPIA #EMA #EU #FDA #HorizonEurope #HTA #innovation #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicinesaccess #medtech #mentalhealth #mhra #NHS #NICE #patients #pharmaregulation #pre-eclampsia #R&D #rarediseases #regulation #regulatory #research #startups #UKgovernment #ukpharma #ukregulation #VPAS AI Biotech COVID-19 Healthcare medicaldevices Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital